Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Nutriband Inc. Nutriband Inc. Announces Seven-for-Six Forward Stock Split July 27, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW 1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company July 26, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market July 22, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares July 15, 2022 From Nutriband Inc. Via AccessWire Topics Lawsuit Exposures Financial Legal Tickers NTRB NTRBW Nutriband Supports Update to CDC Opioid Prescribing Guidelines June 03, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R) May 27, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. to Present at the Emerging Growth Conference on May 25 May 20, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May May 17, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product May 11, 2022 From Nutriband Inc. Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Tickers NTRB NTRBW Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M April 29, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice February 16, 2022 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. To Participate in The Benzinga All Access Event on February 4 February 04, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office January 28, 2022 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology January 18, 2022 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch January 10, 2022 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm January 05, 2022 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety Tickers NTRB NTRBW Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application December 31, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Announces $1 Million Share Repurchase Authorization December 29, 2021 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services December 21, 2021 From Nutriband Inc. Via AccessWire Tickers NTRB NTRBW Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary December 13, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021 December 03, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl November 16, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) November 10, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M October 22, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch October 12, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety Tickers NTRB NTRBW Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO) October 04, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market October 01, 2021 From Nutriband Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Tickers NTRB NTRBW Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.